| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.38 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |